Share on facebook
Share on twitter
Share on linkedin
Share on telegram
Share on whatsapp

U.S. Government Urgently Seeking Data on Puzzling COVID-19 Relapses After Taking Pfizer’s New Pill

U.S. government researchers are urgently planning studies of how often and why SARS-CoV-2 levels rebound in some COVID-19 patients who have completed a five-day course of treatment with Pfizer’s Paxlovid.

“It is a priority,” said Clifford Lane, deputy director for clinical research at the National Institute of Allergy and Infectious Diseases, calling the issue “a pretty urgent thing for us to get a handle on.” The agency is discussing a variety of possible epidemiological and clinical studies to examine post-Paxlovid rebound with scientists at the CDC, he said.

Little is known about the rebound cases, including how frequently they occur.

The only case reported in the medical literature is a preprint posted Tuesday (April 26) on Research Square by researchers at the VA Boston Healthcare System.

    Joe Biden: Pandemic is Over

    Joe Biden during an interview on 60Minutes says he believes the COVID pandemic is Over. 850 more unvaxxed NYC teachers, aides fired for not complying

    Lockdowns Harms Impossible to Cover Up

    “According to a recent study by the World Bank, published in the journal Nature, lockdowns and the response to Covid-19 have pushed an additional 75

    Contagious Vaccines: A Warning

    Brownstone Institute – For two decades scientists have been quietly developing self-spreading contagious vaccines. The NIH funded this research, in which either DNA from a deadly

    VAERS Reports as of 6/10/2022 Release

    28,859 Deaths where Vaccine is COVID19 1,301,356 Adverse Events where Vaccine is COVID19 Search Vaccine Reactions Using MedAlertsA Powerful VAERS Database Search Engine hosted by

    0
    Would love your thoughts, please comment.x
    ()
    x

    Get in Touch!

    Purpose of your Contact
    Where can i reach you?
    What would you like to discuss?
    [crypto-donation-box]

    Are you intending to visit the Lorphic marketing agency?